Recent News

Bladder Drug Manufacturers Face Lawsuits Over Retinal Damage Linked to Elmiron

On Wednesday, August 12th, women in two separate complaints filed suit against units of Johnson & Johnson, Bayer and Teva Pharmaceuticals USA Inc. after they developed eye damage after taking bladder medication Elmiron. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the latest updates in Elmiron litigation and what it means for patients…

Read More...

Jury Awards $27.8 Million in Damages to Patient Injured by Xarelto®

On December 5, 2017, a Philadelphia jury ordered Bayer AG and Johnson & Johnson to pay over $27 million in damages to a patient injured by the companies’ most lucrative medication, Xarelto®. In a verdict that marks the first patient victory in the ongoing Xarelto® litigation, a Philadelphia jury ordered Bayer AG and Johnson &…

Read More...

Xarelto®: A Year in Review

In November, 2015, the U.S. District Court for the Eastern District of Louisiana announced that the first of the Xarelto® bellwether trials, stemming from the Xarelto® multidistrict litigation, would begin in February, 2017. Since that announcement, there have been many updates in the ongoing legal battle against Xarelto® manufacturer Bayer AG and distributer Janssen Pharmaceuticals….

Read More...

Blood Thinner Safety: What to Know When Taking Xarelto

Blood clots have the ability to prevent blood flow to patients’ organs such as the heart, lungs, and kidneys, potentially causing stroke and other life-threatening health conditions. There are many different medications on the market today that aim to reduce the risk of dangerous health conditions such as deep vein thrombosis, blood clot and stroke….

Read More...

Recognizing the Dangerous Effects of Blood Thinners

Anticoagulants are a powerful way to prevent blood clots and stroke in atrial fibrillation patients, as these medications work by increasing blood flow within a patient’s body. However, these medications can also cause severe internal bleeding events which can lead to a number of serious and potentially fatal health complications. When prescribed an anticoagulant medication,…

Read More...

Defective INR Device Used in Xarelto Clinical Trials

In February 2016, BMJ, a medical journal based in the United Kingdom, published a report detailing the use of a faulty device in the Xarelto clinical trials. The Alere international normalized ratio (INR) monitoring device was used to measure blood clotting in patients taking warfarin during the ROCKET-AF clinical trials. The report reveals that the…

Read More...

Xarelto Bellwether Trials to Begin in 2017

Dates have been selected for the first Xarelto multidistrict litigation hearings. Pretrial discovery and bellwether trial selection for the Xarelto multidistrict litigation (MDL) has begun.  The first trials will consist of a selection of four cases, from a pool of forty, that have been considered to represent the majority of the cases filed around the…

Read More...